President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare ...

President Donald Trump signed an executive order on Tuesday that lowers drug prices through the Medicare drug price ...

President Donald Trump’s promise to impose tariffs on pharmaceutical imports is raising red flags among generic drugmakers and industry experts, who warn that such a move could lead to increased drug ...

Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...

Leading pharmacy benefit managers are shifting away from lucrative rebates on biologic drugs and toward lower-cost biosimilar ...

Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who ...

JC Scott, CEO and president of The Pharmaceutical Care Management Association, discusses current efforts in increasing biosimilar adoption and pharmacy benefit manager (PBM) reform.

Celltrion Inc., a major South Korean biopharmaceutical firm, said Monday it has obtained an interchangeability approval for ...

Wockhardt will deepen its novel antibiotics pipeline over the next five years and focus on building a biosimilar business for ...

Reed said, "Congress must prioritize the use of safe, effective and lower-cost biosimilars to address America’s skyrocketing prescription drug costs. President Trump and his administration have ...

The development marks a key regulatory milestone for the company and reinforces investor confidence in Biocon’s growing biosimilar portfolio. The newly approved drug, JOBEVNE (bevacizumab-nwgd ...

Biosimilars offer affordable medical treatments, but regulatory guidelines need updating to ensure safety, efficacy, and accessibility.